Literature DB >> 19300362

Oral lichen planus and oral lichenoid lesions; a critical appraisal with emphasis on the diagnostic aspects.

Isaac van der Waal1.   

Abstract

Oral lichen planus (OLP) has a prevalence of approximately 1%. The etiopathogenesis is poorly understood. The annual malignant transformation is less than 0.5%. There are no effective means to either predict or to prevent such event. Oral lesions may occur that to some extent look like lichen planus but lacking the characteristic features of OLP, or that are indistinguishable from OLP clinically but having a distinct cause, e.g. amalgam restoration associated. Such lesions are referred to as oral lichenoid lesions (OLLs). The management of OLP and the various OLLs may be different. Therefore, accurate diagnosis should be aimed at.

Entities:  

Mesh:

Year:  2009        PMID: 19300362

Source DB:  PubMed          Journal:  Med Oral Patol Oral Cir Bucal        ISSN: 1698-4447


  38 in total

1.  Amalgam contact hypersensitivity lesion: an unusual presentation-report of a rare case.

Authors:  Bk Ramnarayan; Pm Maligi; T Smitha; Us Patil
Journal:  Ann Med Health Sci Res       Date:  2014-09

Review 2.  Oral manifestations of dermatologic disease: a focus on lichenoid lesions.

Authors:  Susan Müller
Journal:  Head Neck Pathol       Date:  2011-01-11

3.  FoxP3(+) T regulatory cells in oral lichen planus and its correlation with the distinct clinical appearance of the lesions.

Authors:  Joabe S Pereira; Bárbara V Monteiro; Cassiano F Nonaka; Éricka J Silveira; Márcia C Miguel
Journal:  Int J Exp Pathol       Date:  2012-08       Impact factor: 1.925

4.  Comparison of serum lipid parameters between patients with classic cutaneous lichen planus and oral lichen planus.

Authors:  Ozlem Ozbagcivan; Sevgi Akarsu; Fatma Semiz; Emel Fetil
Journal:  Clin Oral Investig       Date:  2019-05-25       Impact factor: 3.573

Review 5.  Drug-induced oral lichenoid reactions: a real clinical entity? A systematic review.

Authors:  Giulio Fortuna; Massimo Aria; Julie H Schiavo
Journal:  Eur J Clin Pharmacol       Date:  2017-09-13       Impact factor: 2.953

6.  Lichenoid Dysplasia-A Case Report with a Review of Differential Diagnosis.

Authors:  Kumud Mittal; Mihir Jha; Roopa S Patil; Shekhar Kapoor
Journal:  J Clin Diagn Res       Date:  2017-05-01

7.  Gene expression based evidence of innate immune response activation in the epithelium with oral lichen planus.

Authors:  Guy R Adami; Alexander C F Yeung; Grant Stucki; Antonia Kolokythas; Herve Y Sroussi; Robert J Cabay; Igor Kuzin; Joel L Schwartz
Journal:  Arch Oral Biol       Date:  2014-01-04       Impact factor: 2.633

8.  A comparative study of toluidine blue-mediated photodynamic therapy versus topical corticosteroids in the treatment of erosive-atrophic oral lichen planus: a randomized clinical controlled trial.

Authors:  Hasan Hoseinpour Jajarm; Farnaz Falaki; Majid Sanatkhani; Meysam Ahmadzadeh; Farzaneh Ahrari; Hooman Shafaee
Journal:  Lasers Med Sci       Date:  2014-12-09       Impact factor: 3.161

9.  Folate and Vitamin B12 Levels in Thai Patients with Oral Lichenoid Related Drug.

Authors:  Kobkan Thongprasom; Tin Panyawaraphon; Thanapat Pathomkulmai; Sahaphon Hungsaprug
Journal:  Acta Stomatol Croat       Date:  2015-09

10.  Analysis of the psychopathological profile, quality of life, and cost-effectiveness of oral lichen planus patients treated with photobiomodulation.

Authors:  Sérgio Sousa Sobral; Eloíza Helena da Silva Brandão; Camila de Barros Gallo; Angela Molon; Ana Paula Taboada Sobral; Daniela de Fátima Teixeira da Silva; Lara Jansiski Motta; Adriana Lino Dos Santos Franco; Maria Fernanda Setúbal Destro Rodrigues
Journal:  Clin Oral Investig       Date:  2021-07-12       Impact factor: 3.573

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.